Skip to content

The effect of walking on fatigue in leukemia patients

The Effect of planned Walking on Fatigue-Related Experiences in adult patients with Acute Leukemia Undergoing Chemotherapy .

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017041932788N2
Enrollment
46
Registered
2017-06-06
Start date
2017-01-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myeloblastic leukemia. Refractory anaemia with excess blasts in transformation

Interventions

The intervention group: 10 day wallking planned.
The intervention group: 10 day wallking planned

Sponsors

Vice chancellor for research of Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: (Inclusion criteria: adult patients with acute leukemia who are aware of their disease; Acute leukemia patients who have received at least two chemotherapy sessions; Age range (60-18) years; Patient do not have history of heart disease, diabetes mellitus, hypertension; before walking have normal vital signs Exclusion criteria: patient's inability to participate in two sessions walking; any unusual changes in vital signs, including pulse, blood pressure and breathing during walking; patient died; Not wanting to continue working)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Fatigue. Timepoint: Before the intervention, the end of fifth day of , the end of the tenth day after the intervention. Method of measurement: brief fatigue inventory questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFateme Gheyasi

Ahvaz University of Medical Sciences

gheyasi.f@ajums.ac.ir+98 613332368

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026